Deep Tech Opportunities Report
News
Proxima raises $80M in seed financing, led by DCVC, to reprogram protein-protein interactions
Deep Tech Opportunities Report
DCVC DTOR 2025: We must get better at managing methane
News
Noetik’s partnership with GSK puts dollar signs on the AI licensing business model in TechBio
Deep Tech Opportunities Report
DCVC DTOR 2025: The increasing volatility of electrical supply and demand means it’s time to invest more in grid-stabilizing technologies
Company Profile
Why Kanvas built its own production line for microbiome therapeutics
Thoughts
Quantum’s super position
News
Mythic raises $125M to break through AI’s power wall
News
Radiant raises $300 million+ Series D toward portable nuclear energy at scale
Deep Tech Opportunities Report
DCVC DTOR 2025: One way to stop adding carbon to the air is to get the carbon we need from the air
Deep Tech Opportunities Report
DCVC DTOR 2025: Skyrocketing electric demand requires deeper investments in carbon-free energy
News
Fervo raises $462M to power the grid’s zero-carbon future
News
Relation unveils atopic diseases agreement with Novartis—$55 million up front and up to $1.7 billion in milestone-based payments; DCVC, NVIDIA NVentures, and Magnetic Ventures co-lead $26M fundraise
DCVC Announcements
27
In The Media
399
Endpoints News
Exclusive: GSK to pay $50M to use Noetik's AI cancer models
Noetik
Endpoints News
Exclusive: Relation, Deerfield agree to form new companies from discovered drug targets
Relation
Axios
Radiant boosts round to $350M amid nuclear fervor
Radiant
The Economist
An AI revolution in drugmaking is under way
Recursion Pharmaceuticals
Unlearn
2025 Deep Tech Opportunities Report
DCVC’s partners share their thoughts on the most compelling areas of prospective deep tech investment in 2025 and beyond.